Hikma Pharmaceuticals Share News (HIK)

LONDON BRIEFING: Hikma Leads Decliners In Soft Start To New Month

Hikma Pharmaceuticals trims guidance on generics business

(ShareCast News) - Hikma Pharmaceuticals said most of its businesses have performed well in the year to date, although the generics division is currently below its expectations due to slower-than-expected growth in colchicine sales. The company said it continues to see good demand for legacy product

Hikma Pharmaceuticals Warns On Generic Business Amid Sluggish Sales

Earnings, Trading Statements Calendar - Week Ahead

LONDON MARKET CLOSE: Oil, Gold Stocks Boost UK Shares Ahead Of Fed

Basilia And Hikma Sign Distribution And Supply Deal For Zevtera

U.S. appeals court upholds Shire's patents on hyperactivity drug

By Brendan Pierson Sept 24 (Reuters) - A U.S. appeals court has upheld drugmaker Shire's patents for its top-selling drug Vyvanse, blocking five generic drug makers from launching cheaper versions of the drug to treat attention deficit hyperactivity before 2023. The U.S. Federal Circu

Dividends Calendar - Week Ahead

DIRECTOR DEALINGS SUMMARY: GVC Chair, CEO Buy Shares After Bwin Deal

DIRECTOR DEALINGS: Hikma Pharmaceuticals CFO Sells 20,000 Shares

London midday: Stocks higher after China exports fall less than forecast

(ShareCast News) - London stocks were sitting higher after a better-than-expected report on Chinese exports lifted sentiment. China's exports dropped 5.5% in August from a year earlier in dollar terms after a 8.3% drop in July, according to the General Administration of Customs, better than the 6.6%

TOP NEWS SUMMARY: Insurance M&A Continues As Mitsui Sumitomo Buys Amlin

Hikma Pharmaceuticals inks deal to buy Egypt-based EIMC United

(ShareCast News) - Hikma Pharmaceuticals has agreed to acquire almost the entire share capital of Egypt-based EIMC United Pharmaceuticals (EUP) from a consortium of shareholders for an undisclosed sum. EUP is a pharmaceutical manufacturing company specialising in oncology products and Hikma said the

UPDATE 1-Hikma says to buy Egyptian pharma firm EIMC United

(Adds details, background, share movement) Sept 8 (Reuters) - Hikma Pharmaceutical Plc said it would buy nearly the entire share capital of EIMC United Pharmaceuticals, a drugmaker specialising in oncology products, from a consortium of shareholders to boost its position in the Egyptian mar

LONDON BRIEFING: Amlin Agrees To Be Bought By Mitsui Sumitomo Insurance